Federal tick and mosquito disease program extended through 2030

What does this do?

HR 4348 renews the Kay Hagan Tick Act, which was set to expire after 2025, extending it through 2030. The program funds regional research centers focused on tick- and insect-borne diseases and provides grants to state and local health departments to detect and respond to outbreaks. The renewal also adds a requirement that regional centers more specifically work on improving their ability to identify, report, prevent, and respond to these illnesses.

Who does it affect?

The bill affects people living in areas where tick- or mosquito-borne diseases are common, which covers large parts of the United States. It also directly affects researchers at universities and medical centers that receive program funding, and state and local health department workers who use the grants to track and respond to outbreaks.

Why does it matter?

Cases of vector-borne diseases such as Lyme disease, Rocky Mountain spotted fever, and West Nile virus have been rising across the United States. Renewing the program continues existing public health infrastructure rather than establishing something new, which means any lapse in funding would have interrupted ongoing research and response efforts.

What does it cost, and who pays?

• Funds regional research centers
• Grants to state and local health depts
• No dollar amount specified